Livagen 20mg

£44.90

Livagen is a synthetic tetrapeptide (Lys-Glu-Asp-Ala) used as a research tool to investigate peptide-mediated regulation of gene expression and chromatin accessibility in cell-culture systems.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 99% (HPLC)
  • CAS Number: N/A
  • Molecular Formula: C18H31N5O9
  • Amino Acid Sequence: Lys-Glu-Asp-Ala (KEDA)

In stock

Add to Cart
Livagen 20mg
Livagen 20mg
£44.90
  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Dedicated customer support

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides
  • Batch HPLC tested at ≥ 99% purity
  • Storage: –20 °C long term; 2–8 °C short term
  • Sold for research purposes only

Livagen

Synonyms / Designations: Livagen; KEDA; Lys-Glu-Asp-Ala; synthetic short peptide
Amino Acid Sequence: Lys-Glu-Asp-Ala (KEDA)
CAS Number: 195875-84-4
Molecular Formula: C18H31N5O9
Molecular Weight: 461.47 g/mol
Purity: ≥ 99% (HPLC)
Appearance: White to off-white lyophilised powder
Pack Size: 20 mg (total)
Storage: Desiccated, protected from light, stored at –20 °C or below
Solubility: Soluble in water and buffered aqueous solutions

Description & Mechanism

Livagen (KEDA) is studied in vitro as a chromatin-directed short-peptide probe. In lymphocyte and hepatocyte cultures it has been reported to induce chromatin decondensation (de-heterochromatinisation), activating ribosomal genes and releasing genes repressed by condensation of euchromatic regions, used experimentally to study gene-expression and protein-synthesis programmes in cultured cells.

It is a tool for probing chromatin-level transcriptional regulation in immune and hepatic cell systems. Observed effects depend on concentration, model system and exposure conditions.

Applications in Research

  • In-vitro lymphocyte chromatin-activation and ribosomal-gene studies
  • Hepatocyte gene-expression and protein-synthesis research
  • Reference probe for short-peptide transcriptional regulation

Specifications Summary

ParameterTypical Value / Range
Purity (HPLC)≥ 99%
AppearanceWhite to off-white lyophilised powder
Molecular Weight461.47 g/mol
Peptide TypeSynthetic tetrapeptide
SolubilityWater, buffered aqueous solutions
Storage–20 °C, desiccated, dark
Pack Size20 mg (total)

Precautions & Notes

  • Experimental behaviour is dependent on concentration, model system and exposure conditions
  • Appropriate experimental controls are recommended
  • Prolonged exposure to light, elevated temperature or aqueous environments may reduce stability
  • Intended strictly for laboratory research use; not for human or veterinary application

References

Khavinson VKh, Popovich IG, et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053.
https://www.mdpi.com/1420-3049/26/22/7053

PubChem Compound Summary, CID 87919683 (Lys-Glu-Asp-Ala).
https://pubchem.ncbi.nlm.nih.gov/compound/87919683

Keywords: Livagen, KEDA, short peptide, synthetic tetrapeptide, chromatin